Anoveb

Medicinal product

(Invented) name

Anoveb

Active substance (s)

Tiamino hidrochloridas/Piridoksino hidrochloridas/Cianokobalaminas

Strength

100 mg/100 mg/1 mg/2 ml

Pharmaceutical form

injekcinis tirpalas

Route (s) of administration

leisti į raumenis

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

ATC code (s)

A11DB, Vitamin B1 in combination with vitamin B6 and/or vitamin B12

Marketing authorisation holder

SIA Ingen Pharma, Latvija

Date of authorisation

2019-06-20

Date of renewal

2023-12-14

Documents

Stage

Perregistruotas

Controlled?

Controlled substance type

Legal basis

10(1)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Ampulėje (2 ml) yra	2 ml
Tiamino hidrochloridas	100 mg
Piridoksino hidrochloridas	100 mg
Cianokobalaminas	1 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
101971	88073	1088073	ampulė	2 ml N5		Receptinis	LT/1/19/4405/001	Tiekiama	-	-	No	-	-	Download
101972	88074	1088074	ampulė	2 ml N10		Receptinis	LT/1/19/4405/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2023-12-14	Perregistruotas
2019-06-20	Registruotas